Rebollo María J, San Juan Garrido Rafael, Folgueira Dolores, Palenque Elia, Díaz-Pedroche C, Lumbreras Carlos, Aguado José M
Unit of Infectious Diseases, University Hospital 12 de Octubre, Madrid 28041, Spain.
Diagn Microbiol Infect Dis. 2006 Oct;56(2):141-6. doi: 10.1016/j.diagmicrobio.2006.03.018. Epub 2006 May 15.
The aim of the study was to assess the utility of the polymerase chain reaction (PCR) assay in blood and urine for the diagnosis of tuberculosis (TB). We prospectively evaluated the usefulness of PCR performed in blood and urine samples from patients with proved or probable TB compared with a control group of patients. The PCR technique was performed using IS6110 primers. We included in the study 57 patients (43 with definite TB and 14 with probable TB) and 26 controls. Blood and urine samples were drawn at the time of microbiologic diagnosis and 3, 6, 9, and 12 months later. Cultures were positive in the early period (<1 month after treatment) in 11 of 57 patients (19%) with probable or definite TB, in comparison with 42% of patients (24/57) who yielded a positive PCR (P = 0.02). Urine samples increased the sensitivity of PCR determination in blood samples by 10%. The PCR in blood and/or urine was positive in 41% of patients with pulmonary TB, in 36% of patients with extrapulmonary TB, and in 50% of patients with disseminated TB. Mycobacterium tuberculosis was still detectable by PCR in 5 of 13 patients with cured TB after 1 or more months of antituberculous treatment. The PCR detection of M. tuberculosis in blood and urine samples is useful for the diagnosis of different clinical forms of TB, mostly in those patients in which sample extraction is difficult or requires aggressive techniques. The sensitivity of this technique could be improved studying more than 1 sample in each patient, even after initiating an antituberculous treatment.
本研究的目的是评估聚合酶链反应(PCR)检测在血液和尿液中诊断结核病(TB)的效用。我们前瞻性地评估了在已确诊或疑似结核病患者的血液和尿液样本中进行PCR检测的有效性,并与一组对照患者进行了比较。PCR技术使用IS6110引物进行。本研究纳入了57例患者(43例确诊结核病,14例疑似结核病)和26例对照。在微生物学诊断时以及之后的3、6、9和12个月采集血液和尿液样本。在疑似或确诊结核病的57例患者中,有11例(19%)在治疗早期(治疗后<1个月)培养结果呈阳性,相比之下,PCR检测呈阳性的患者为42%(24/57)(P = 0.02)。尿液样本使血液样本中PCR检测的灵敏度提高了10%。肺结核患者中41%、肺外结核患者中36%以及播散性结核患者中50%的血液和/或尿液PCR检测呈阳性。在接受抗结核治疗1个月或更长时间后,13例治愈的结核病患者中有5例仍可通过PCR检测到结核分枝杆菌。血液和尿液样本中结核分枝杆菌的PCR检测对于诊断不同临床类型的结核病很有用,主要适用于那些样本采集困难或需要采用侵入性技术的患者。即使在开始抗结核治疗后,通过对每位患者检测多个样本,该技术的灵敏度可能会提高。